Novo Nordisk Aktie
48,37
EUR
+0,11
EUR
+0,22
%
45,80
CHF
+0,57
CHF
+1,26
%
Werbung
Novo Nordisk Aktie Analyse
| 11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
| 05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
| 29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
|
Werbung
|
|||
| 12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.03.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
| 03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
| 26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
| 07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
| 14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
| 05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
Werbung
Werbung